<DOC>
	<DOC>NCT02418156</DOC>
	<brief_summary>Objective is to actively gather information on the use of CorMatrix ECM for vascular repair in the reconstruction of the femoral artery.</brief_summary>
	<brief_title>A Study on the Use of CorMatrix ®ECM® for Femoral Arterial Reconstruction</brief_title>
	<detailed_description />
	<mesh_term>Vascular Diseases</mesh_term>
	<mesh_term>Peripheral Vascular Diseases</mesh_term>
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<criteria>1. Subjects must be undergoing femoral arterial reconstruction with patch angioplasty closure 2. Surgeon intends to use CorMatrix ECM per FDA cleared Indications for Use 3. Subject possesses ability to provide informed consent 4. Subject expresses understanding and willingness to fulfill all expected requirements of protocol 1. Known sensitivity to porcine material</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>